85 related articles for article (PubMed ID: 21039037)
1. Caveolin-1 promotes mammary tumorigenesis: mutational profile of the Kashmiri population.
Syeed N; Husain SA; Abdullah S; Sameer AS; Chowdri NA; Nanda MS; Siddiqi MA
Asian Pac J Cancer Prev; 2010; 11(3):689-96. PubMed ID: 21039037
[TBL] [Abstract][Full Text] [Related]
2. Mutational profile of the CAV-1 gene in breast cancer cases in the ethnic Kashmiri population.
Syeed N; Husain SA; Abdullah S; Sameer AS; Chowdri NA; Nanda MS; Siddiqi MA
Asian Pac J Cancer Prev; 2010; 11(4):1099-105. PubMed ID: 21133631
[TBL] [Abstract][Full Text] [Related]
3. 5'-CpG island promoter hypermethylation of the CAV-1 gene in breast cancer patients of Kashmir.
Syeed N; Hussain F; Husain SA; Siddiqi MA
Asian Pac J Cancer Prev; 2012; 13(1):371-5. PubMed ID: 22502704
[TBL] [Abstract][Full Text] [Related]
4. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.
Lee H; Park DS; Razani B; Russell RG; Pestell RG; Lisanti MP
Am J Pathol; 2002 Oct; 161(4):1357-69. PubMed ID: 12368209
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of prohibitin--a highly conserved gene in Indian female breast cancer cases.
Najm MZ; Akhtar MS; Ahmad I; Sadaf ; Mallick MN; Kausar MA; Chattopadhyay S; Ahad A; Zaidi S; Husain SA; Siddiqui WA
Asian Pac J Cancer Prev; 2012; 13(10):5113-7. PubMed ID: 23244120
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status.
Li T; Sotgia F; Vuolo MA; Li M; Yang WC; Pestell RG; Sparano JA; Lisanti MP
Am J Pathol; 2006 Jun; 168(6):1998-2013. PubMed ID: 16723714
[TBL] [Abstract][Full Text] [Related]
8. Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers.
Sotgia F; Rui H; Bonuccelli G; Mercier I; Pestell RG; Lisanti MP
Cancer Res; 2006 Nov; 66(22):10647-51. PubMed ID: 17108100
[TBL] [Abstract][Full Text] [Related]
9. Non-existence of caveolin-1 gene mutations in human breast cancer.
Patani N; Lambros MB; Natrajan R; Dedes KJ; Geyer FC; Ward E; Martin LA; Dowsett M; Reis-Filho JS
Breast Cancer Res Treat; 2012 Jan; 131(1):307-10. PubMed ID: 21909981
[TBL] [Abstract][Full Text] [Related]
10. High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families.
Katagiri T; Kasumi F; Yoshimoto M; Nomizu T; Asaishi K; Abe R; Tsuchiya A; Sugano M; Takai S; Yoneda M; Fukutomi T; Nanba K; Makita M; Okazaki H; Hirata K; Okazaki M; Furutsuma Y; Morishita Y; Iino Y; Karino T; Ayabe H; Hara S; Kajiwara T; Houga S; Miki Y
J Hum Genet; 1998; 43(1):42-8. PubMed ID: 9609997
[TBL] [Abstract][Full Text] [Related]
11. Mutational, epigenetic and expressional analyses of caveolin-1 gene in breast cancers.
Chen ST; Lin SY; Yeh KT; Kuo SJ; Chan WL; Chu YP; Chang JG
Int J Mol Med; 2004 Oct; 14(4):577-82. PubMed ID: 15375584
[TBL] [Abstract][Full Text] [Related]
12. p27/Kip1 mutation found in breast cancer.
Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
[TBL] [Abstract][Full Text] [Related]
13. The diversity in the expression profile of caveolin II transcripts, considering its new transcript in breast cancer.
Ariana M; Arabi N; Pornour M; Vaseghi H; Ganji SM; Alivand MR; Salari M; Akbari ME
J Cell Biochem; 2018 Feb; 119(2):2168-2178. PubMed ID: 28857238
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.
Sotgia F; Del Galdo F; Casimiro MC; Bonuccelli G; Mercier I; Whitaker-Menezes D; Daumer KM; Zhou J; Wang C; Katiyar S; Xu H; Bosco E; Quong AA; Aronow B; Witkiewicz AK; Minetti C; Frank PG; Jimenez SA; Knudsen ES; Pestell RG; Lisanti MP
Am J Pathol; 2009 Mar; 174(3):746-61. PubMed ID: 19234134
[TBL] [Abstract][Full Text] [Related]
15. Caveolin involvement and modulation in breast cancer.
Aoki MN; Amarante MK; Oda JM; Watanabe MA
Mini Rev Med Chem; 2011 Nov; 11(13):1143-52. PubMed ID: 22353223
[TBL] [Abstract][Full Text] [Related]
16. The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families.
Konecny M; Vizvaryova M; Weismanova E; Ilencikova D; Mlkva I; Weismann P; Machackova G; Kausitz J
Neoplasma; 2007; 54(2):137-42. PubMed ID: 17319787
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer.
Sagara Y; Mimori K; Yoshinaga K; Tanaka F; Nishida K; Ohno S; Inoue H; Mori M
Br J Cancer; 2004 Aug; 91(5):959-65. PubMed ID: 15305200
[TBL] [Abstract][Full Text] [Related]
18. Absence of the caveolin-1 P132L mutation in cancers of the breast and other organs.
Koike S; Kodera Y; Nakao A; Iwata H; Yatabe Y
J Mol Diagn; 2010 Sep; 12(5):712-7. PubMed ID: 20581046
[TBL] [Abstract][Full Text] [Related]
19. The Relationship Between 6 Polymorphisms of Caveolin-1 Gene and the Risk of Breast Cancer.
Fard ZT; Nafisi N
Clin Breast Cancer; 2018 Oct; 18(5):e893-e898. PubMed ID: 29525429
[TBL] [Abstract][Full Text] [Related]
20. Using Caveolin-1 epithelial immunostaining patterns to stratify human breast cancer patients and predict the Caveolin-1 (P132L) mutation.
Mercier I; Bryant KG; Sotgia F; Bonuccelli G; Witkiewicz AK; Dasgupta A; Jasmin JF; Pestell RG; Lisanti MP
Cell Cycle; 2009 May; 8(9):1396-401. PubMed ID: 19342880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
